The signaling tool box for tyrosine-based costimulation of lymphocytes

Current Opinion in Immunology

Volumn 23, Issue 3, 2011, Pages 324-329

  Engels, Niklas ^a   Wienands, Jürgen ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN TAIL TYROSINE; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN INTERACTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTES; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TYROSINE;

EID: 79957774025     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.01.005     Document Type: Review

References (54)

1. Reth M. Antigen receptor tail clue. Nature 1989, 338:383-384.
2. Engels N., Engelke M., Wienands J. Conformational plasticity and navigation of signaling proteins in antigen-activated B lymphocytes. Adv Immunol 2008, 97:251-281.
3. Guy C.S., Vignali D.A. Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev 2009, 232:7-21.
4. Daeron M., Jaeger S., Du Pasquier L., Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 2008, 224:11-43.
5. Engels N., Konig L.M., Heemann C., Lutz J., Tsubata T., Griep S., Schrader V., Wienands J. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol 2009, 10:1018-1025.
6. Klinman N.R. The mechanism of antigenic stimulation of primary and secondary clonal precursor cells. J Exp Med 1972, 136:241-260.
7. Klinman N.R., Doughty R.A. Hapten-specific stimulation of secondary B cells independent of T cells. J Exp Med 1973, 138:473-478.
8. Yefenof E., Sanders V.M., Uhr J.W., Vitetta E.S. In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen. J Immunol 1986, 137:85-90.
9. Hebeis B.J., Klenovsek K., Rohwer P., Ritter U., Schneider A., Mach M., Winkler T.H. Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 2004, 199:593-602.
10. Weisel F.J., Appelt U.K., Schneider A.M., Horlitz J.U., van Rooijen N., Korner H., Mach M., Winkler T.H. Unique requirements for reactivation of virus-specific memory B lymphocytes. J Immunol 2010, 185:4011-4021.
11. Martin S.W., Goodnow C.C. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol 2002, 3:182-188.
12. Horikawa K., Martin S.W., Pogue S.L., Silver K., Peng K., Takatsu K., Goodnow C.C. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med 2007, 204:759-769.
13. Kaisho T., Schwenk F., Rajewsky K. The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. Science 1997, 276:412-415.
14. Waisman A., Kraus M., Seagal J., Ghosh S., Melamed D., Song J., Sasaki Y., Classen S., Lutz C., Brombacher F., et al. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med 2007, 204:747-758.
15. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., King F., Roberts T., Ratnofsky S., Lechleider R.J., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993, 72:767-778.
16. Fujimoto M., Poe J.C., Hasegawa M., Tedder T.F. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification. Immunol Res 2000, 22:281-298.
17. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397:263-266.
18. June C.H., Ledbetter J.A., Linsley P.S., Thompson C.B. Role of the CD28 receptor in T-cell activation. Immunol Today 1990, 11:211-216.
19. Crooks M.E., Littman D.R., Carter R.H., Fearon D.T., Weiss A., Stein P.H. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol Cell Biol 1995, 15:6820-6828.
20. Dennehy K.M., Elias F., Na S.Y., Fischer K.D., Hunig T., Luhder F. Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome. J Immunol 2007, 178:1363-1371.
21. Kim H.H., Tharayil M., Rudd C.E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J Biol Chem 1998, 273:296-301.
22. Pages F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J., Olive D. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 1994, 369:327-329.
23. Prasad K.V., Cai Y.C., Raab M., Duckworth B., Cantley L., Shoelson S.E., Rudd C.E. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci USA 1994, 91:2834-2838.
24. Dodson L.F., Boomer J.S., Deppong C.M., Shah D.D., Sim J., Bricker T.L., Russell J.H., Green J.M. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Mol Cell Biol 2009, 29:3710-3721.
25. Holdorf A.D., Green J.M., Levin S.D., Denny M.F., Straus D.B., Link V., Changelian P.S., Allen P.M., Shaw A.S. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med 1999, 190:375-384.
26. Tai X., Van Laethem F., Sharpe A.H., Singer A. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proc Natl Acad Sci USA 2007, 104:13756-13761.
27. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., Mak T.W., Ohashi P.S., Rottapel R. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol 2001, 2:325-332.
28. Gigoux M., Shang J., Pak Y., Xu M., Choe J., Mak T.W., Suh W.K. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci USA 2009, 106:20371-20376.
29. Rolf J., Bell S.E., Kovesdi D., Janas M.L., Soond D.R., Webb L.M., Santinelli S., Saunders T., Hebeis B., Killeen N., et al. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol 2010, 185:4042-4052.
30. Chan A.S., Mobley J.L., Fields G.B., Shimizu Y. CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase. J Immunol 1997, 159:934-942.
31. Stillwell R., Bierer B.E. T cell signal transduction and the role of CD7 in costimulation. Immunol Res 2001, 24:31-52.
32. Sempowski G.D., Lee D.M., Scearce R.M., Patel D.D., Haynes B.F. Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes. J Exp Med 1999, 189:1011-1016.
33. Witherden D.A., Verdino P., Rieder S.E., Garijo O., Mills R.E., Teyton L., Fischer W.H., Wilson I.A., Havran W.L. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science 2010, 329:1205-1210.
34. Jameson J., Havran W.L. Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev 2007, 215:114-122.
35. Verdino P., Witherden D.A., Havran W.L., Wilson I.A. The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science 2010, 329:1210-1214.
36. Lanier L.L. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009, 227:150-160.
37. Diefenbach A., Tomasello E., Lucas M., Jamieson A.M., Hsia J.K., Vivier E., Raulet D.H. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002, 3:1142-1149.
38. Gilfillan S., Ho E.L., Cella M., Yokoyama W.M., Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002, 3:1150-1155.
39. Billadeau D.D., Upshaw J.L., Schoon R.A., Dick C.J., Leibson P.J. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol 2003, 4:557-564.
40. Zompi S., Hamerman J.A., Ogasawara K., Schweighoffer E., Tybulewicz V.L., Di Santo J.P., Lanier L.L., Colucci F. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol 2003, 4:565-572.
41. Orr M.T., Sun J.C., Hesslein D.G., Arase H., Phillips J.H., Takai T., Lanier L.L. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med 2009, 206:807-817.
42. Colucci F., Schweighoffer E., Tomasello E., Turner M., Ortaldo J.R., Vivier E., Tybulewicz V.L., Di Santo J.P. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol 2002, 3:288-294.
43. Bryceson Y.T., Long E.O. Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 2008, 20:344-352.
44. Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D., Leibson P.J. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat Immunol 2006, 7:524-532.
45. Neumann K., Oellerich T., Urlaub H., Wienands J. The B-lymphoid Grb2 interaction code. Immunol Rev 2009, 232:135-149.
46. Gogishvili T., Elias F., Emery J.L., McPherson K., Okkenhaug K., Hunig T., Dennehy K.M. Proliferative signals mediated by CD28 superagonists require the exchange factor Vav1 but not phosphoinositide 3-kinase in primary peripheral T cells. Eur J Immunol 2008, 38:2528-2533.
47. Schneider H., Rudd C.E. CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription. Biochem Biophys Res Commun 2008, 369:616-621.
48. Okkenhaug K., Fruman D.A. PI3Ks in lymphocyte signaling and development. Curr Top Microbiol Immunol 2010, 346:57-85.
49. Engelke M., Engels N., Dittmann K., Stork B., Wienands J. Ca(2+) signaling in antigen receptor-activated B lymphocytes. Immunol Rev 2007, 218:235-246.
50. Oh-hora M., Rao A. Calcium signaling in lymphocytes. Curr Opin Immunol 2008, 20:250-258.
51. Fayard E., Xue G., Parcellier A., Bozulic L., Hemmings B.A. Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway. Curr Top Microbiol Immunol 2010, 346:31-56.
52. Deane J.A., Kharas M.G., Oak J.S., Stiles L.N., Luo J., Moore T.I., Ji H., Rommel C., Cantley L.C., Lane T.E., et al. T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 2007, 109:2894-2902.
53. Inabe K., Ishiai M., Scharenberg A.M., Freshney N., Downward J., Kurosaki T. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J Exp Med 2002, 195:189-200.
54. Vigorito E., Bardi G., Glassford J., Lam E.W., Clayton E., Turner M. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J Immunol 2004, 173:3209-3214.